Docosahexaenoic acid potentiates interleukin-1β induction of nitric oxide synthase through mechanism involving p44/42 MAPK activation in rat vascular smooth muscle cells

被引:32
作者
Hirafuji, M [1 ]
Machida, T
Tsunoda, M
Miyamoto, A
Minami, M
机构
[1] Hlth Sci Univ Hokkaido, Fac Pharmaceut Sci, Dept Pharmacol, Ishikari, Hokkaido 0610293, Japan
[2] Sapporo Med Univ, Sch Med, Dept Pharmacol, Sapporo, Hokkaido 0608556, Japan
关键词
docosahexaenoic acid; nitric oxide; inducible nitric oxide synthase; mitogen-activated protein kinase; vascular smooth muscle cells; cardiovascular protection;
D O I
10.1038/sj.bjp.0704768
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1 The effect of docosahexaenoic acid (DHA) on nitric oxide (NO) production and inducible NO synthase (iNOS) expression induced by interleukin (IL)-1beta, and whether the effect of DHA is related to its effect on mitogen-activated protein kinase (MAPK) activation were investigated in cultured rat vascular smooth muscle cells (VSMCs). 2 DHA and eicosapentaenoic acid (EPA), although less potent, increased the NO production induced by IL-1beta (3 ng ml(-1)) in a concentration-dependent manner (3 - 30 muM) Arachidonic acid had no significant effect. The stimulatory effect of DHA (30 muM) on the NO production was more obvious at lower concentrations of IL-1beta. 3 IL-1beta induced iNOS protein and mRNA expressions, which were significantly potentiated by DHA. EPA (30 muM) had a tendency to increase the iNOS protein and mRNA expressions, but arachidonic acid had no effect. 4 IL-1beta-induced iNOS protein expression was significantly inhibited by PD 98059 (10 muM), a selective inhibitor of p44/42 MAPK kinase, both in the absence and the presence of DHA. SB 203580 (10 muM), a selective inhibitor of p38 MAPK activity, had no significant effect, although had a tendency to inhibit slightly. 5 IL-1beta increased the phosphorylation of p44/42 MAPK, while it did not apparently increase the phosphorylation of p38 MAPK. DHA significantly potentiated the IL-1beta-induced phosphorylation of p44/42 MAPK, while it had no significant effect on the phosphorylation of p38 MAPK. 6 These results suggest that DHA increases NO production by potentiating iNOS expression induced by IL-1beta through mechanism involving p44/42 MAPK signalling cascade in rat VSMCs. The present study may contribute to the understanding of basic mechanisms underlying the beneficial effects of DHA on various cardiovascular disorders.
引用
收藏
页码:613 / 619
页数:7
相关论文
共 38 条
[21]  
KIMURA S, 1995, BIOGENIC AMINES, V11, P195
[22]  
LAWSON DL, 1991, EICOSANOIDS, V4, P217
[23]   CARDIOVASCULAR EFFECTS OF N-3 FATTY-ACIDS [J].
LEAF, A ;
WEBER, PC .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (09) :549-557
[24]   Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide [J].
Lo, CJ ;
Chiu, KC ;
Fu, MJ ;
Chu, A ;
Helton, S .
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION, 2000, 24 (03) :159-163
[25]  
LOWRY OH, 1951, J BIOL CHEM, V193, P265
[26]   NITRIC-OXIDE SYNTHASE ACTIVITY IN GENETIC-HYPERTENSION [J].
MALINSKI, T ;
KAPTURCZAK, M ;
DAYHARSH, J ;
BOHR, D .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1993, 194 (02) :654-658
[27]  
Mano Mark T., 1995, Blood Pressure, V4, P177, DOI 10.3109/08037059509077591
[28]   The cardiovascular protective role of docosahexaenoic acid [J].
McLennan, P ;
Howe, P ;
Abeywardena, M ;
Muggli, R ;
Raederstorff, D ;
Mano, M ;
Rayner, T ;
Head, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1996, 300 (1-2) :83-89
[29]   DIETARY FISH OIL AUGMENTS NITRIC-OXIDE PRODUCTION OR RELEASE IN PATIENTS WITH TYPE-2 (NON-INSULIN-DEPENDENT) DIABETES-MELLITUS [J].
MCVEIGH, GE ;
BRENNAN, GM ;
JOHNSTON, GD ;
MCDERMOTT, BJ ;
MCGRATH, LT ;
HENRY, WR ;
ANDREWS, JW ;
HAYES, JR .
DIABETOLOGIA, 1993, 36 (01) :33-38
[30]   Dietary docosahexaenoic acid increases cerebral acetylcholine levels and improves passive avoidance performance in stroke-prone spontaneously hypertensive rats [J].
Minami, M ;
Kimura, S ;
Endo, T ;
Hamaue, N ;
Hirafuji, M ;
Togashi, H ;
Matsumoto, M ;
Yoshioka, M ;
Saito, H ;
Watanabe, S ;
Kobayashi, T ;
Okuyama, H .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (04) :1123-1129